Cognivue

Cognivue®’s FDA-cleared technology digitally assesses cognitive functioning.

We strive to deliver on our mission to provide cognitive assessment tools to a broad range of healthcare providers for the early detection of cognitive changes.

11/24/2025

One of the most powerful aspects of Cognivue’s technology is its use of adaptive psychophysics—a science-driven method that personalizes each assessment in real time.

In our recent webinar, “Measuring What Matters: Integrating Cognitive Assessment into Geriatric Care Pathways,” Dr. Ardeshir Z. Hashmi of the Cleveland Clinic explained it best. In the clip below, he describes how an adaptive test should work:

➡️ If a patient answers correctly, the system increases difficulty—one step at a time.
➡️ When they reach their limit, it confirms that threshold with similar-level tasks.
➡️ That point becomes the patient’s unique cognitive fingerprint, which can be tracked over time.

This is precisely how Cognivue technology works—adapting each assessment in real time, calibrating to a patient’s motor and visual abilities, and adjusting difficulty until it identifies their performance limits.

Watch the full webinar On Demand (link in comments).

11/19/2025

🧠 Cognivue is headed to San Diego for the 2025 Clinical Trials on Alzheimer’s Disease CTAD Conference — taking place December 1-4!

📅 Don’t miss the chance to meet with Dr. James E. Galvin, Chief Scientific Officer, and Heather M. Harris, Sr. VP of Scientific Affairs & Partnerships. Email events@cognivue.com to schedule a meeting.

📍 Catch our poster presentation!
📌 Poster | Wednesday, December 3 | 7:15 AM – 5:30 PM
🧪 “Combining Cognivue Clarity and Lucent AD Complete for a Time and Cost Efficient Two Stage Screening for Alzheimer's Disease Clinical Trial Recruitment Enrichment and Treatment Protocols”

We’re looking forward to connecting, collaborating, and contributing to advances in Alzheimer’s clinical research. See you at !

11/11/2025

🧠 Why measure cognitive function? Because what we don’t measure, we can’t manage.

Cognitive changes impact every aspect of aging—from medication safety and mobility to social engagement and care planning. Yet routine cognitive assessment remains underused in clinical practice.

On November 19, join Dr. Ardeshir Z. Hashmi (Cleveland Clinic) and Dr. Joy Siegel (Nova Southeastern University) for forward-looking discussion on advancing geriatric care through earlier, data-driven cognitive assessment and its growing role in value-based care.

📅 November 19, 2025 | 1 PM EST / 10 AM PST
👉 Register now: https://bit.ly/47MsDIQ

Cognivue

11/06/2025

🧠 1 Week Away! Webinar #5 of 5
How do we turn breakthrough research into real-world clinical impact?

On November 13, join James E. Galvin, MD, MPH for the final webinar in our series:
📘 Precision Without Complexity: Cognitive and Amyloid Risk Detection Built for Real-World Clinical Practice

🎥 Register to join live or watch on demand: https://bit.ly/4lVEfOZ

Cognivue

11/04/2025

🌟 Cognivue is heading to Boston for the Gerontological Society of America (GSA) Annual Scientific Meeting — November 12–15!

Visit us at Booth #220 to experience Cognivue Clarity®, our digital cognitive assessment device that provides an objective, comprehensive evaluation of cognitive performance in about 10 minutes.

👋 If you’re attending, stop by to see how our technology supports cognitive health across the aging continuum—from research to real-world care.

10/28/2025

Medication Management is important to your overall health ( )! Reviewing your medications with your healthcare provider or pharmacist is an integral part of medication management. You have the power to optimize your cognition by adopting a combination of key healthy lifestyle habits and being aware of your overall wellness.

10/24/2025

🧠 Final Webinar in Our 5-Part Series | November 13
It all comes together here—turning peer-reviewed evidence into real-world practice with James E. Galvin, MD, MPH, Chief Scientific Officer at Cognivue.

📘 Topic:
Precision Without Complexity: Cognitive and Amyloid Risk Detection Built for Real-World Clinical Practice

This closing session integrates findings from four peer-reviewed Cognivue journal publications—covering psychometric validation, normative ranges, amyloid-risk identification using biomarker-established reference standards, and the Cognivue Amyloid Risk Measure (CARM*).

Dr. Galvin will connect the dots between research and practice, showing how Cognivue Clarity® is designed for real-world clinical workflows:
• Helping clinicians detect cognitive change earlier
• Supporting meaningful conversations with patients and caregivers
• Enabling personalized care pathways that improve outcomes

🎥 Join live or watch on demand: https://bit.ly/3JFbpF9

*patent pending

10/22/2025

Cognivue named “Top Cognitive Impairment Early Detection Solution 2025” and featured as the October Cover Story in Healthcare Tech Outlook.

Cognivue has been recognized by Healthcare Tech Outlook as the Top Cognitive Impairment Early Detection Solution for 2025, further solidifying its leadership in advancing timely cognitive assessment. To highlight the achievement, Healthcare Tech Outlook profiled Cognivue in a four-page cover story in its October issue.

“Too often, cognitive change goes unrecognized until it begins to impact daily life,” said Paul W. Estes, President and CEO of Cognivue. “Cognivue’s FDA-cleared technology is designed to give clinicians practical, objective insight earlier—helping integrate cognitive assessment into routine care. This award reflects our ongoing commitment to research, innovation, and making early detection a reality across healthcare.”

Read the full Healthcare Tech Outlook feature here: ➡️ https://bit.ly/4o1oMP0

10/20/2025

⏰ Webinar #4 is this week!
Don’t miss the next session in our 5-part series with James E. Galvin, MD, MPH, Chief Scientific Officer at Cognivue.

📘 Topic:
Establishing the Standard: Psychometric Validation and Normative Data for Cognivue Clarity® Across Diverse Populations

📅 Thursday, October 23, 2025

🎥 Register to join live or watch on demand: https://bit.ly/46aNLI7

10/17/2025

🚨 Cognivue Webinar Registration Now Open
Measuring What Matters: Integrating Cognitive Assessment into Geriatric Care Pathways

We’re honored to host Dr. Ardeshir Z. Hashmi, MD, MBA, FACP, FNAP, AGSF — Endowed Chair of Geriatric Innovation and Section Chief of the Center for Geriatric Medicine at the Cleveland Clinic — for a live expert interview on the future of cognitive assessment in geriatric care.

🔍 In this 1-hour conversation, we’ll explore:
✅ How innovation and leadership in geriatrics are moving cognitive evaluation into the standard of care
✅ The challenges of incorporating cognitive assessment into patient visits
✅ How cognitive assessment can guide better care planning and outcomes

🎙️ Speakers:
• Dr. Ardeshir Z. Hashmi — Cleveland Clinic
• Dr. Joy Siegel, EdD, MBA — Nova Southeastern University

📅 November 19, 2025 | 🕐 1 PM EST / 10 AM PST
👉 Secure your seat: https://bit.ly/3INWyYW

10/15/2025

🔔 Only 2 Weeks Away! 🔔
Don’t miss our upcoming webinar:
“Unlocking Precision Care: Integrating Cognitive Insights into Hearing Treatment Plans”

🗓️ October 29, 2025 | 🕐 1PM (EST) / 10AM (PST)

In this free 60-minute session hosted by Cognivue, our expert panel will explore practical ways to turn cognitive insights into more comprehensive hearing care—with real-world examples of referral pathways and interdisciplinary collaboration.

🎙️ Expert Panel:
• Dr. Jill Davis, AuD
• Dr. Keith Darrow, PhD, CCC-A
• Dr. Diego Cahn-Hidalgo, MD, FACP
• Dr. Joy Siegel, EdD, MBA (Moderator)

🔗 Save Your Spot: https://bit.ly/3IIPL2v

10/13/2025

🌟 Excited to share that Cognivue will be exhibiting at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly 2025 in Salt Lake City, UT — October 22–26!

Come visit us at Booth #1603 to learn about Cognivue Clarity®, our digital cognitive assessment device that delivers an objective and comprehensive cognitive analysis in about 10-minutes.

👋 If you're attending, stop by and say hello — we'd love to meet you and show you how our cognitive assessment works.

Address

7911 Rae Boulevard
Victor, NY
14564

Telephone

+15852031969

Website

https://www.cognivue.com/

Alerts

Be the first to know and let us send you an email when Cognivue posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cognivue:

Shortcuts

Want your practice to be the top-listed Clinic in Victor?

A Path to Cognitive Health and Peace of Mind

Cognivue® is the world’s first FDA-cleared test of cognitive function. Cognivue objectively, quantitatively and reliably identifies changes in cognitive function that could be indicative of an impairment that you may optimally treat or manage. It’s personalized, consistent and reliable.